Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification of the Effects of Isoniazid Treatment on Erythrocyte and Plasma Protoporphyrin IX Concentration and Plasma Aminolevulinic Acid in Patients With Erythropoietic Protoporphyria

NCT01550705 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT01550705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification of the Effects of Isoniazid Treatment on Erythrocyte and Plasma Protoporphyrin IX Concentration and Plasma Aminolevulinic Acid in Patients With Erythropoietic Protoporphyria
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2012
Completion date
December 31, 2015
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoietic protoporphyria (epp), x linked erythropoietic protoporphyria